Literature DB >> 10882710

Meropenem pharmacokinetics and pharmacodynamics in patients with ventilator-associated pneumonia.

F de Stoppelaar, L Stolk, F van Tiel, A Beysens, S van der Geest, P de Leeuw.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10882710     DOI： 10.1093/jac/46.1.150

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

1.  Appropriate antibiotic dosage levels in the treatment of severe sepsis and septic shock.

Authors:  Fabio Silvio Taccone; Maya Hites; Marjorie Beumier; Sabino Scolletta; Frédérique Jacobs
Journal:  Curr Infect Dis Rep       Date:  2011-10       Impact factor: 3.725

2.  Evaluation by monte carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteers.

Authors:  Wolfgang A Krueger; Jurgen Bulitta; Martina Kinzig-Schippers; Cornelia Landersdorfer; Ulrike Holzgrabe; Kurt G Naber; George L Drusano; Fritz Sörgel
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

3.  Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.

Authors:  Fabio Silvio Taccone; Pierre-François Laterre; Thierry Dugernier; Herbert Spapen; Isabelle Delattre; Xavier Wittebole; Daniel De Backer; Brice Layeux; Pierre Wallemacq; Jean-Louis Vincent; Frédérique Jacobs
Journal:  Crit Care       Date:  2010-07-01       Impact factor: 9.097

Review 4.  Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams.

Authors:  Joao Gonçalves-Pereira; Pedro Póvoa
Journal:  Crit Care       Date:  2011-09-13       Impact factor: 9.097

5.  Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic-derived dose justification for phase 3 studies in patients with nosocomial pneumonia.

Authors:  Alan J Xiao; Benjamin W Miller; Jennifer A Huntington; David P Nicolau
Journal:  J Clin Pharmacol       Date:  2015-08-25       Impact factor: 3.126

6.  Assessment of pharmacokinetic changes of meropenem during therapy in septic critically ill patients.

Authors:  João Goncalves-Pereira; Nuno Elvas Silva; André Mateus; Catarina Pinho; Pedro Povoa
Journal:  BMC Pharmacol Toxicol       Date:  2014-04-14       Impact factor: 2.483
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.